Literature DB >> 11839426

The impact of pain and symptoms of depression in scleroderma.

Lisa M Benrud-Larson1, Jennifer A Haythornthwaite, Leslie J Heinberg, Christy Boling, Jeffrey Reed, Barbara White, Fredrick M Wigley.   

Abstract

Systemic sclerosis (scleroderma) is a rare connective tissue disease that can affect multiple organ systems. Case reports and small treatment studies suggest that pain is significant in scleroderma, but few data speak of the frequency or impact of pain. This study sought to determine the frequency and impact of pain, symptoms of depression, and social network characteristics on physical functioning and social adjustment in patients with scleroderma. One hundred and forty-two scleroderma patients completed measures of pain, depressive symptoms, social network characteristics, physical functioning, and social adjustment. Sixty-three percent reported at least mild pain and 50% reported at least mild levels of depressive symptomatology. Hierarchical regression analyses revealed that pain, depressive symptoms, and employment status (disabled/unemployed vs. not) were significant, independent predictors of physical functioning, together accounting for 37% of the total variance. Pain was the single strongest predictor of physical function, accounting for 20% of the variance. Depressive symptoms, physical functioning, diversity of social network, and employment status were significant independent predictors of social adjustment, together accounting for 63% of the variance. Depressive symptoms were the single strongest predictor of social adjustment, accounting for 26% of the variance. The effects of pain and physical function on social adjustment became non-significant when depressive symptoms were entered into the model, suggesting that symptoms of depression mediate the effect of pain and physical function on social adjustment. These findings indicate that pain is common in scleroderma and that pain and depressive symptoms are significant determinants of physical functioning and social adjustment, two important components of health-related quality of life. Increased attention to effective management of pain and symptoms of depression in scleroderma will likely lead to improved functioning and quality of life.

Entities:  

Mesh:

Year:  2002        PMID: 11839426     DOI: 10.1016/S0304-3959(01)00409-2

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  26 in total

1.  New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN).

Authors:  Brett D Thombs; Lisa R Jewett; Shervin Assassi; Murray Baron; Susan J Bartlett; Angela Costa Maia; Ghassan El-Baalbaki; Daniel E Furst; Karen Gottesman; Jennifer A Haythornthwaite; Marie Hudson; Ann Impens; Annett Korner; Catarina Leite; Maureen D Mayes; Vanessa L Malcarne; Sarosh J Motivala; Luc Mouthon; Warren R Nielson; Diane Plante; Serge Poiraudeau; Janet L Poole; Janet Pope; Maureen Sauve; Russell J Steele; Maria E Suarez-Almazor; Suzanne Taillefer; Cornelia H van den Ende; Erin Arthurs; Marielle Bassel; Vanessa Delisle; Katherine Milette; Allison Leavens; Ilya Razykov; Dinesh Khanna
Journal:  Clin Exp Rheumatol       Date:  2012-05-29       Impact factor: 4.473

2.  Depression among the Moroccan systemic sclerosis.

Authors:  Fahd Wafki; Bouchra Amine; Yousra Ibn Yacoub; Assia Laatiriss; Fatima Znat; Redouane Abouqal; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2011-06-01       Impact factor: 2.980

Review 3.  Negative affect in systemic sclerosis.

Authors:  Leticia Leon; Lydia Abasolo; Marta Redondo; Miguel Angel Perez-Nieto; Luis Rodriguez-Rodriguez; Maria Isabel Casado; Rafael Curbelo; Juan Angel Jover
Journal:  Rheumatol Int       Date:  2013-09-27       Impact factor: 2.631

4.  Longitudinal patterns of pain in patients with diffuse and limited systemic sclerosis: integrating medical, psychological, and social characteristics.

Authors:  Erin L Merz; Vanessa L Malcarne; Scott C Roesch; Deepthi K Nair; Gloria Salazar; Shervin Assassi; Maureen D Mayes
Journal:  Qual Life Res       Date:  2016-07-28       Impact factor: 4.147

Review 5.  (Not) talking about sex: a systematic comparison of sexual impairment in women with systemic sclerosis and other chronic disease samples.

Authors:  Ruby Knafo; Brett D Thombs; Lisa Jewett; Marie Hudson; Fred Wigley; Jennifer A Haythornthwaite
Journal:  Rheumatology (Oxford)       Date:  2009-08-19       Impact factor: 7.580

6.  Sleep quality in patients with systemic sclerosis: relationship between the clinical variables, depressive symptoms, functional status, and the quality of life.

Authors:  Mustafa Akif Sariyildiz; Ibrahim Batmaz; Mahmut Budulgan; Mehtap Bozkurt; Levent Yazmalar; Ahmet Inanir; Tahsin Celepkolu; Remzi Çevik
Journal:  Rheumatol Int       Date:  2013-01-31       Impact factor: 2.631

Review 7.  A systematic comparison of fatigue levels in systemic sclerosis with general population, cancer and rheumatic disease samples.

Authors:  B D Thombs; M Bassel; L McGuire; M T Smith; M Hudson; J A Haythornthwaite
Journal:  Rheumatology (Oxford)       Date:  2008-08-13       Impact factor: 7.580

8.  Use of the Patient-generated Index in systemic sclerosis to assess patient-centered outcomes.

Authors:  Sofia de Achaval; Michael A Kallen; Maureen D Mayes; Maria A Lopez-Olivo; Maria E Suarez-Almazor
Journal:  J Rheumatol       Date:  2013-06-15       Impact factor: 4.666

9.  Fatigue: an overlooked determinant of physical function in scleroderma.

Authors:  S B Sandusky; L McGuire; M T Smith; F M Wigley; J A Haythornthwaite
Journal:  Rheumatology (Oxford)       Date:  2008-12-23       Impact factor: 7.580

10.  Biopsychosocial typologies of pain in a cohort of patients with systemic sclerosis.

Authors:  Erin L Merz; Vanessa L Malcarne; Shervin Assassi; Deepthi K Nair; Tiffany A Graham; Brayden P Yellman; Rosa M Estrada-Y-Martin; Maureen D Mayes
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-04       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.